Last reviewed · How we verify
NCT05899959: RECAMO
REmote CArdiac MOnitoring by the Corsano CardioWatch 287-2 Evaluation Study
trial testing Corsano CardioWatch 287-2 in Atrial Fibrillation in 190 participants. Completed in 28 December 2023.
28 December 2023
Quick facts
| Lead sponsor | Corsano Health B.V. |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 190 |
| Start date | 15 June 2023 |
| Primary completion | 28 December 2023 |
| Estimated completion | 28 December 2023 |
| Sites | 1 location across Netherlands |
Drugs / interventions tested
- Corsano CardioWatch 287-2
Conditions studied
- Atrial Fibrillation — all drugs for Atrial Fibrillation →
- Rhythm; Disorder — all drugs for Rhythm; Disorder →
- Palpitations — all drugs for Palpitations →
- Hypertension — all drugs for Hypertension →
Sponsor
Corsano Health B.V.
Who can join
18 and older, any sex, with Atrial Fibrillation or Rhythm; Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
In this study, a wristband that monitors hearth rhythm and blood pressure is assessed in free living conditions. Two groups of patients are being recruited: patients receiving an EKG holter and patients receiving an automatic blood pressure monitor. Patients wear the wristband for 28 days. During this time, the number of atrial fibrillation episodes detected by the wristband is being counted, which is to be compared with the number of episodes detected by the holter. Also, blood pressure is measured continuously, which is to be compared with daily blood pressure measurements using a conventional blood pressure cuff.
Publications & conference data
3 peer-reviewed publications reference this trial (live from Europe PMC):
-
Evaluation of a novel cuffless photoplethysmography-based wristband for measuring blood pressure according to the regulatory standards.
van Vliet M, Monnink SHJ, Kuiper MJ, Constandse JC, et al · · 2024 · cited 10× · PMID 38774367 · DOI 10.1093/ehjdh/ztae006 -
Ambulatory atrial fibrillation detection and quantification by wristworn AI device compared to standard holter monitoring.
van Vliet M, Aalberts JJJ, Hamelinck C, Hauer AD, et al · · 2025 · cited 3× · PMID 40133622 · DOI 10.1038/s41746-025-01555-9 -
Assessment of photoplethysmography-based blood pressure determinations during long-term and short-term remote cardiac monitoring: the RECAMO study.
van Vliet M, Aalberts JJJ, Hamelinck C, Hauer AD, et al · · 2025 · PMID 40703134 · DOI 10.1093/ehjdh/ztaf027
Verify or expand the search:
- PubMed search for NCT05899959
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Atrial Fibrillation
Currently open trials in the same condition.
- NCT07429214 — A Study of VARIPULSE Catheter and TRUPULSE Generator With VARIPULSE Pro Software in Participants With PAF or PsAF · NA · recruiting
- NCT07271238 — Feasibility Study on the VERAFEYE Imaging and Navigation System for Guided Catheter Ablation Procedures · NA · recruiting
- NCT07388108 — Atrial Dyssynchrony to Predict Arrhythmias in the Postoperative Setting of Cardiovascular Surgery. · recruiting
- NCT07428967 — AV Node Ablation and CONDUCTion System Pacing for Atrial Fibrillation With Preserved Left Ventricular Function · NA · recruiting
- NCT06650995 — AlEX-DHF: Ablation and Exercise in Diastolic Heart Failure · NA · recruiting
Other Corsano Health B.V. trials
Trials by the same sponsor.
- NCT06508619 — Blood Pressure Treatment by the Corsano CardioWatch 287-2 Evaluation Study · NA · recruiting
- NCT05566886 — Validation of a Vital Signs Monitoring Wristband · completed
- NCT05542732 — Accuracy of CardioWatch 287-2 During Profound Hypoxia · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05899959 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Corsano Health B.V.
- Last refreshed: 26 August 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05899959.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing